MagnePath, an Australian company, is a digital health-medtech crossover that sees a way to reduce the time and cost of liver biopsies by using MRI scans to help map the liver. The company claims its images to measure fat, inflammation, iron and fibrosis in the liver are much clearer than the current standard of care.
Reference and further reading :
MR image mapping or noninvasive liver biopsy
4/ 5Oleh Habifa